Special Issue

Explainable Artificial Intelligence in Biomedicine

Submission Deadline: 30 Apr 2024

Guest Editor

  • Portrait of Guest Editor Nguyen Quoc Khanh  Le

    Nguyen Quoc Khanh Le PhD

    Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

    Interests: Position Weight Matrix; Jackknife; Support Vector Machine; Membrane Proteins; Barrels; Prediction; Texture Analysis; Cancer; Fluorodeoxyglucose F 18

    Special Issue in IMR Press journals

Special Issue Information

Dear Colleagues,

Explainable Artificial Intelligence (XAI) is an approach in AI that prioritizes the transparency and interpretability of decision-making processes. In the field of biomedicine, XAI has the potential to revolutionize the way that medical diagnosis, treatment and research are conducted.

One of the main benefits of XAI in biomedicine is its ability to provide insight into the decision-making processes of AI models. This is especially important in medical applications where human lives are at stake and thus when it is critical to understand how AI models reach their conclusions. XAI can help to ensure that decisions made by AI are not just accurate, but also understandable and trustworthy. Moreover, XAI can help to ensure that any potential biases are detected and addressed, thus improving the quality and fairness of medical decisions. Another area where XAI has potential application in biomedicine is in the development of personalised medicine. XAI can be used to identify complex patterns in patient data that are not easily discernible to human doctors. This can help to provide a more individualised approach to patient care and lead to better health outcomes.

This special issue aims to collect articles on the application of XAI in different areas of biomedicine.

Dr. Nguyen Quoc Khanh Le

Guest Editor

Keywords

  • big data
  • bioinformatics
  • biomedical informatics
  • clinical decision support system
  • disease diagnosis
  • drug discovery
  • explainable artificial intelligence
  • genomics
  • machine learning
  • medical imaging

Published Papers (2)

Open Access Review

A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool

Luca Saba, Mahesh Maindarkar, Narendra N. Khanna, Amer M. Johri, Laura Mantella, John R. Laird, Kosmas I. Paraskevas, Zoltan Ruzsa, Manudeep K. Kalra, Jose Fernandes E. Fernandes, Seemant Chaturvedi, Andrew Nicolaides, Vijay Rathore, Narpinder Singh, Mostafa M. Fouda, Esma R. Isenovic, Mustafa Al-Maini, Vijay Viswanathan, Jasjit S. Suri

Front. Biosci. (Landmark Ed) 2023, 28(10), 248; https://doi.org/10.31083/j.fbl2810248

(This article belongs to the Special Issue Explainable Artificial Intelligence in Biomedicine)

591
205
12